A commission proposed a new definition of obesity focused on how excess fat affects the body, rather than assessing body mass ...

New recommendations on how to define obesity would reduce the emphasis on body mass index and take into account health ...

The way the world defines obesity has been in need of an overhaul, according to some experts, and it could be coming soon ...

T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.

an obesity expert at the University of Washington and one of the 58 authors of the report published in The Lancet Diabetes & Endocrinology journal. The report introduces two new diagnostic ...

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...

The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks ...

As evidence has mounted that new diabetes and weight loss drugs can provide a variety of health benefits, the FDA has ...

GLP-1 weight loss drugs - such as Wegovy and Mounjaro - may reduce risk of conditions including Alzheimer’s disease and ...

The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...